Fampridine SR

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Fampridine SR

Postby bromley » Mon Sep 25, 2006 6:00 am

One of the companies I monitor closely is Acorda Therapeutics who are focussed on restoring neurological function. Here are the results from the Fampridine trial which is to improve walking.


http://phx.corporate-ir.net/phoenix.zht ... highlight=
User avatar
bromley
Family Elder
 
Posts: 1889
Joined: Fri Sep 10, 2004 3:00 pm

Advertisement

Postby bromley » Mon Sep 25, 2006 9:09 am

Here is the NMSS article on this drug.

http://www.nationalmssociety.org/research-2006Sep25.asp

The results are not that great - only 35% of people experienced an increase in walking speed and the average increase in walking speed was 25%. As usual, there was a death on the trial - although a few weeks after the trial period ended.

Ian
User avatar
bromley
Family Elder
 
Posts: 1889
Joined: Fri Sep 10, 2004 3:00 pm


Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users